{"tool_name":"deepcdr","contents":["biotools","bioschemas"],"fetched_metadata":{"biotools":{"id":"deepcdr","home":"https://github.com/kimmo1019/DeepCDR","license":"MIT","summary":"DeepCDR is a hybrid graph convolutional network for cancer drug response prediction. It takes both multi-omics data of cancer cell lines and drug structure as inputs and predicts the drug sensitivity (binary or contineous IC50 value).\n\nDeepCDR is a hybrid graph convolutional network for cancer drug response prediction. It takes both multi-omics data of cancer cell lines and drug structure as inputs and predicts the drug sensitivity (binary or contineous IC50 value).\n\nThis work has been accepted to ECCB2020 and was also published in the journal Bioinformatics.","addition_date":"2021-01-18T09:53:32Z","last_update_date":"2021-02-24T15:37:15Z","tool_type":["Command-line tool"]},"bioschemas":{"name":"DeepCDR","home":"https://bio.tools/deepcdr","license":"MIT","summary":"DeepCDR is a hybrid graph convolutional network for cancer drug response prediction. It takes both multi-omics data of cancer cell lines and drug structure as inputs and predicts the drug sensitivity (binary or contineous IC50 value).\n\nDeepCDR is a hybrid graph convolutional network for cancer drug response prediction. It takes both multi-omics data of cancer cell lines and drug structure as inputs and predicts the drug sensitivity (binary or contineous IC50 value).\n\nThis work has been accepted to ECCB2020 and was also published in the journal Bioinformatics.","tool_type":"sc:SoftwareApplication"}}}